Quillaja is an evergreen tree native to Chile, best known for producing natural compounds called saponins that foam like soap when mixed with water. You’ve likely encountered quillaja extract without realizing it: it creates the frothy head on certain soft drinks, works as a natural emulsifier in foods, and plays a critical role in two major modern vaccines. The tree’s name comes from “küllay,” a word from the indigenous Mapuche people of Chile meaning “soap.”
The Soapbark Tree
Quillaja saponaria, commonly called the soapbark tree or quillay, belongs to its own plant family, Quillajaceae. It grows naturally across warm, temperate regions of central Chile and northward into Peru. In its native habitat, the tree can reach over 50 feet tall with pendulous branches and an ashy bark. In cultivation outside South America, it typically stays around 30 feet. It’s a broadleaf evergreen that sometimes forms multiple trunks, and it produces small greenish-yellow, star-shaped flowers during the Chilean summer months of December through February.
How Quillaja Saponins Work
The tree’s bark contains saponins, a class of compounds found throughout the plant kingdom but especially concentrated in quillaja. Each saponin molecule has two parts: a fat-friendly (lipophilic) core and a water-friendly (hydrophilic) sugar chain attached to it. This dual nature is what makes saponins behave like soap or detergent.
When you dissolve quillaja saponins in water and agitate them, the fat-friendly portion of each molecule orients itself away from the water while the sugar portion faces toward it. This lowers the surface tension of the liquid and causes the molecules to cluster into tiny structures called micelles. The practical result is a rich, persistent foam and the ability to blend ingredients that don’t normally mix, like oil and water.
Quillaja in Food and Drinks
Quillaja extract is an approved food additive in both the United States and the European Union. The FDA considers one form of it (type 1 extract) to have no safety questions as a foaming agent in beverages at levels up to 500 milligrams of dry weight per kilogram. In the EU, it’s authorized as additive E 999 for use in flavored drinks and cider at a maximum of 200 milligrams per liter.
Its most visible role is as the foaming agent in carbonated soft drinks. Product labeling data shows quillaja appearing most often in carbonated soft drinks, followed by beer, poultry products, beverage concentrates, and iced tea. It also has approved or proposed uses in confectionery, chewing gum, soups, snack foods, and coffee or tea products, all at low concentrations. In every case, it serves the same basic function: creating stable foam or helping ingredients blend smoothly as an emulsifier.
A Key Ingredient in Modern Vaccines
One of quillaja’s most important applications has nothing to do with food. A highly purified fraction of quillaja saponin called QS-21 is used as a vaccine adjuvant, a substance that strengthens the body’s immune response to a vaccine. Two major vaccines rely on it.
Shingrix, the shingles vaccine licensed by the FDA in 2017, contains QS-21 as part of its adjuvant system. So does Mosquirix, the first malaria vaccine, which received regulatory approval from the European Medicines Agency in 2015 for use in sub-Saharan Africa.
QS-21 boosts immunity through several pathways. It helps immune cells take up vaccine components more efficiently by interacting with cholesterol in cell membranes, creating small pores that allow the vaccine’s target proteins to enter the cell interior for processing. It also activates an immune signaling complex called the inflammasome, triggering the release of inflammatory signals that push the immune system toward a strong, balanced response involving both antibody production and the activation of killer T cells. This combination of effects makes QS-21 especially valuable for vaccines targeting diseases where antibodies alone aren’t enough.
Cosmetic and Personal Care Uses
The European Commission’s cosmetic ingredients database lists several quillaja-derived materials, including bark extract, root extract, and wood extract. Depending on the preparation, these serve as antidandruff agents, cleansers, emulsifiers, foaming agents, moisturizers, and skin conditioners. The same soap-like properties that make quillaja useful in beverages translate directly to shampoos, facial cleansers, and other personal care products, where it can replace synthetic surfactants with a plant-derived alternative.
Safety at Food-Level Doses
Quillaja saponins do have biological activity beyond foaming. In laboratory settings, they can rupture red blood cells (a property called hemolysis), irritate mucous membranes, and show cytotoxic effects at higher concentrations. These effects are dose-dependent and relevant primarily at concentrations far above what appears in food.
In animal feeding studies, rats given quillaja extract in their diet showed no abnormalities in behavior, blood work, urine analysis, or tissue examination at standard dietary levels. At very high concentrations (2 to 4 percent of the diet), male rats had temporarily lower body weight gain and slightly altered liver and stomach weights, but these differences resolved over time and no tissue damage was found on microscopic examination. The levels used in food and beverages are orders of magnitude lower than those causing any observable effects in animal studies.
Interestingly, quillaja saponins have also shown cholesterol-lowering effects in animal research. Rabbits with experimentally induced atherosclerosis that received oral saponins showed normalized blood cholesterol and reduced blood pressure.
Sustainability of Soapbark Harvesting
Because quillaja saponins come primarily from the bark of wild and cultivated trees in Chile, the sustainability of harvesting is an ongoing concern. The soapbark tree has historically been overshadowed by more commercially prominent Chilean species, earning it the nickname “the Cinderella tree” among researchers. Growing global demand, driven by both the food industry and the pharmaceutical need for QS-21 in vaccines, has increased pressure on natural populations. Efforts to cultivate quillaja in plantations and to develop synthetic or recombinant alternatives to QS-21 are underway, but the wild Chilean tree remains the primary commercial source.